Abstract
The UK Medicines Act was enacted in 1968 and its major provisions first came into force in 1971. Broadly speaking the Act controls almost all aspects of manufacture, development and marketing of drugs. The principal variants that it does not control are price, need and supply for administration to healthy volunteers. Price and need are taken into account elsewhere in the Department of Health and Social Security (DHSS) for determining reimbursement of certain groups of products.
Views given are the responsibility of the author and do not represent official policy proposals of the DHSS.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Copyright information
© 1988 The International Federation of Associations of Pharmaceutical Physicians
About this chapter
Cite this chapter
Jones, G. (1988). Regulatory requirements in the UK in the 1990s. In: Burley, D., Haward, C., Mullinger, B. (eds) The Focus for Pharmaceutical Knowledge. Palgrave, London. https://doi.org/10.1007/978-1-349-09571-1_37
Download citation
DOI: https://doi.org/10.1007/978-1-349-09571-1_37
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-09573-5
Online ISBN: 978-1-349-09571-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)